The assessment of lung function and residual hypoxemia after balloon pulmonary angioplasty for patients with non-operable chronic thromboembolic hypertension

Y. Matsuoka (KobeKobe Hyogo, Japan), Y. Taniguchi (Kobe Hyogo, Japan), K. Miwa (Kobe Hyogo, Japan), K. Sumimoto (Kobe Hyogo, Japan), H. Onishi (Kobe Hyogo, Japan), Y. Tsuboi (Kobe Hyogo, Japan), N. Emoto (Kobe Hyogo, Japan), K. Hirata (Kobe Hyogo, Japan)

Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Session: Chronic thromboembolic pulmonary hypertension
Session type: E-poster session
Number: 1536
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Matsuoka (KobeKobe Hyogo, Japan), Y. Taniguchi (Kobe Hyogo, Japan), K. Miwa (Kobe Hyogo, Japan), K. Sumimoto (Kobe Hyogo, Japan), H. Onishi (Kobe Hyogo, Japan), Y. Tsuboi (Kobe Hyogo, Japan), N. Emoto (Kobe Hyogo, Japan), K. Hirata (Kobe Hyogo, Japan). The assessment of lung function and residual hypoxemia after balloon pulmonary angioplasty for patients with non-operable chronic thromboembolic hypertension. 1536

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience
Source: Eur Respir J, 49 (6) 1602409; 10.1183/13993003.02409-2016
Year: 2017



Multi-step therapy with riociguat, balloon pulmonary angioplasty, and cardiac rehabilitation for inoperable chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017


Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2014; 23: 393-395
Year: 2014


French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (5) 1802095; 10.1183/13993003.02095-2018
Year: 2019



Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019


Effects of percutaneous transluminal pulmonary angioplasty on respiratory functions in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015


Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (CTEPH): does it perform as well as we hoped?
Source: International Congress 2018 – New trends in the management of pulmonary hypertension
Year: 2018


Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Medical treatment in persistent pulmonary hypertension after pulmonary thrombendarterectomy in patients with chronic thrombembolic pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 364s
Year: 2006

Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Surgical treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 735-742
Year: 2013



Balloon pulmonary angioplasty (BPA) for inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 263-271
Year: 2015



Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010



Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010


Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?
Source: Eur Respir J, 54 (4) 1901639; 10.1183/13993003.01639-2019
Year: 2019



Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?
Source: Eur Respir J, 53 (5) 1900843; 10.1183/13993003.00843-2019
Year: 2019



Predictive value of CT pulmonary angiography to assess surgical accessibility for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension (CTEPH) patients
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


The relationship of thrombus localization with prognosis and chronic tromboembolic pulmonary hypertension in acute pulmonary thromboembolia
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020